Michael Hamacher, Katrin Marcus, Kai Stühler, "Proteomics in Drug Research"
Wiley-VCH; 1 edition (May 1, 2006) ISBN:3527312269 383 page PDF 3,2 Mb
From
skillful handling of the wide range of technologies to successful
applications in drug discovery—this handbook has all the information
professional proteomics users need.
Edited by experts working at
one of the hot spots in European proteomic research, the numerous
contributions by experts from the pharmaceutical industry and public
proteomics consortia to provide the necessary perspective on current
trends and developments in this exciting field.
Following an
introductory chapter, the book moves on to proteomic technologies, such
as protein biochips, protein-protein interactions, and proteome
analysis in situ. The section on applications includes bioinformatics,
Alzheimer's disease, neuroproteomics, plasma and T-cell proteomics,
differential phosphoproteome analysis and biomarkers, as well as
pharmacogenomics.
Invaluable reading for medicinal and
pharmaceutical chemists, gene technologists, molecular biologists, and
those working in the pharmaceutical industry.
[ندعوك للتسجيل في المنتدى أو التعريف بنفسك لمعاينة هذا الرابط]
Wiley-VCH; 1 edition (May 1, 2006) ISBN:3527312269 383 page PDF 3,2 Mb
From
skillful handling of the wide range of technologies to successful
applications in drug discovery—this handbook has all the information
professional proteomics users need.
Edited by experts working at
one of the hot spots in European proteomic research, the numerous
contributions by experts from the pharmaceutical industry and public
proteomics consortia to provide the necessary perspective on current
trends and developments in this exciting field.
Following an
introductory chapter, the book moves on to proteomic technologies, such
as protein biochips, protein-protein interactions, and proteome
analysis in situ. The section on applications includes bioinformatics,
Alzheimer's disease, neuroproteomics, plasma and T-cell proteomics,
differential phosphoproteome analysis and biomarkers, as well as
pharmacogenomics.
Invaluable reading for medicinal and
pharmaceutical chemists, gene technologists, molecular biologists, and
those working in the pharmaceutical industry.